| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |